Skip to main content

Skin and Connective Tissue Diseases

4
Pipeline Programs
3
Companies
5
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
2
0
2
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

3 companies ranked by most advanced pipeline stage

Leo Pharma
Leo PharmaDenmark - Ballerup
4 programs
2
2
LEO 90100 Aerosol foamPhase 21 trial
LP0113 aerosol sprayPhase 21 trial
Clobetasol propionate 0.05 % ointmentPhase 11 trial
LEO 80185 gel, vehicle, liquid paraffinPhase 11 trial
Active Trials
NCT02355639Completed16Est. Apr 2015
NCT02379793Completed33Est. Apr 2015
NCT02518048Completed35Est. Jan 2016
+1 more trials
Relief Therapeutics
Relief TherapeuticsSwitzerland - Geneva
1 program
A mobile app with AI functionality for diagnosing skin-related NTDsN/A1 trial
Active Trials
NCT07506967Not Yet Recruiting2,420Est. May 2030
Labcorp
LabcorpBURLINGTON, NC
1 program
A mobile app with AI functionality for diagnosing skin-related NTDsN/A

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
Leo PharmaLEO 90100 Aerosol foam
Leo PharmaLP0113 aerosol spray
Leo PharmaLEO 80185 gel, vehicle, liquid paraffin
Leo PharmaClobetasol propionate 0.05 % ointment
Relief TherapeuticsA mobile app with AI functionality for diagnosing skin-related NTDs

Clinical Trials (5)

Total enrollment: 2,554 patients across 5 trials

NCT02518048Leo PharmaLEO 90100 Aerosol foam

A Psoriasis Plaque Test Trial With LEO 90100 Compared to Betesil® in Patients With Psoriasis Vulgaris

Start: Aug 2015Est. completion: Jan 201635 patients
Phase 2Completed
NCT02416258Leo PharmaLP0113 aerosol spray

A Psoriasis Plaque Test Trial With LP0113 Spray in Patients With Psoriasis Vulgaris (LP0113-1123)

Start: Apr 2015Est. completion: Jun 201550 patients
Phase 2Completed
NCT02379793Leo PharmaLEO 80185 gel, vehicle, liquid paraffin

Skin Irritation Test of LEO 80185 Gel in Healthy Japanese Subjects

Start: Mar 2015Est. completion: Apr 201533 patients
Phase 1Completed
NCT02355639Leo PharmaClobetasol propionate 0.05 % ointment

A Single-Centre Clinical Trial to Assess Steroid Induced Skin Atrophy on Healthy Skin

Start: Jan 2015Est. completion: Apr 201516 patients
Phase 1Completed
NCT07506967Relief TherapeuticsA mobile app with AI functionality for diagnosing skin-related NTDs

Early Detection and AI-Based Management of Skin-Related Neglected Tropical Diseases in Sub-Saharan Africa by Frontline Health Workers

Start: May 2026Est. completion: May 20302,420 patients
N/ANot Yet Recruiting

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

3 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.